{"id":"NCT00895011","sponsor":"VIVUS LLC","briefTitle":"Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2011-04","completion":"2011-04","firstPosted":"2009-05-07","resultsPosted":"2012-06-28","lastUpdate":"2012-10-01"},"enrollment":298,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Erectile Dysfunction"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Avanafil","otherNames":["TA-1790","Stendra"]},{"type":"DRUG","name":"Avanafil","otherNames":["TA-1790","Stendra"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Avanafil 100 mg","type":"EXPERIMENTAL"},{"label":"Avanafil 200 mg","type":"EXPERIMENTAL"}],"summary":"The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.","primaryOutcome":{"measure":"Change in Percentage of Sexual Attempts in Which Subjects Are Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo","deltaMin":13.9,"sd":3.42},{"arm":"Avanafil 100 mg","deltaMin":28,"sd":3.54},{"arm":"Avanafil 200 mg","deltaMin":29.4,"sd":3.33}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":35},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":["23219537"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":100},"commonTop":["Headache","Flushing","Nasopharyngitis"]}}